BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline?
Investors buying this biotech stock now will get its pipeline essentially for free.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.